Clinical Trial Update: Dupilumab in Severe Chronic Hand Eczema [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for dupilumab in severe chronic hand eczema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Hand Eczema | Phase 2 | Status: UNKNOWN